Juvenile Dermatomyositis: Pathophysiology and Disease Expression

[1]  A. Reed,et al.  Association of the HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis. , 1995, Human immunology.

[2]  L. Tucker,et al.  von Willebrand factor in juvenile dermatomyositis. , 1995, The Journal of rheumatology.

[3]  L. Pachman,et al.  Pulmonary fibrosis and myositis in a child with anti-Jo-1 antibody. , 1995, The Journal of rheumatology.

[4]  D. Isenberg,et al.  Juvenile dermatomyositis: serial studies of circulating autoantibodies to a 56kD nuclear protein. , 1994, Clinical and experimental rheumatology.

[5]  C. Partain,et al.  Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. , 1994, Arthritis and rheumatism.

[6]  D. Fraser,et al.  Diagnosis of inflammatory myopathy by percutaneous needle biopsy with demonstration of the focal nature of myositis. , 1994, American journal of clinical pathology.

[7]  G. Citera,et al.  Sequential development of 2 connective tissue diseases in juvenile patients. , 1993, The Journal of rheumatology.

[8]  C. Chi,et al.  Juvenile and adult dermatomyositis among the Chinese: a comparative study. , 1993, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

[9]  F. Walker,et al.  Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: dermatomyositis sine myositis? , 1993, Journal of the American Academy of Dermatology.

[10]  M. Černá,et al.  HLA class II alleles in juvenile dermatomyositis. , 1993, The Journal of rheumatology. Supplement.

[11]  M. Ferrarini,et al.  Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Results of a preliminary study. , 1993, Clinical and experimental rheumatology.

[12]  J. Haas,et al.  Childhood polymyositis as a paraneoplastic phenomenon. , 1993, Pediatric neurology.

[13]  L. Miller,et al.  Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. , 1993, The Journal of rheumatology.

[14]  T. Lehman.  Aggressive therapy for childhood rheumatic diseases. When are immunosuppressives appropriate? , 1993, Arthritis and rheumatism.

[15]  N. Talal,et al.  Delayed type hypersensitivity in patients with rheumatoid arthritis. , 1993, The Journal of rheumatology.

[16]  S. Albani,et al.  Recurrent juvenile dermatomyositis and cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5 M protein and human skeletal myosin. , 1992, The Journal of pediatrics.

[17]  L. Tucker,et al.  Methotrexate treatment of recalcitrant childhood dermatomyositis. , 1992, Arthritis and rheumatism.

[18]  M. Ohashi,et al.  Elevated serum immunoglobulin E levels in patients with juvenile dermatomyositis. , 1992, The Journal of allergy and clinical immunology.

[19]  M. Ohashi,et al.  Juvenile Dermatomyositis: A Statistical Study of 114 Patients with Dermatomyositis , 1992, The Journal of dermatology.

[20]  J. Fernandez-Solà,et al.  Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. , 1992, Human pathology.

[21]  M. Dalakas,et al.  Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle , 1992, The Lancet.

[22]  B. Sigurgeirsson,et al.  Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. , 1992, The New England journal of medicine.

[23]  M. Dalakas,et al.  Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. , 2010, Arthritis and rheumatism.

[24]  B. Bridges.  The rashes of dermatomyositis in a black patient. , 1991, The American journal of medicine.

[25]  C. Ober,et al.  Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1 *0501. , 1991, Human immunology.

[26]  M. Dalakas,et al.  A New Approach to the Classification of Idiopathic Inflammatory Myopathy: Myositis‐Specific Autoantibodies Define Useful Homogeneous Patient Groups , 1991, Medicine.

[27]  M. Lecha,et al.  Immunopathologic study of skin lesions in dermatomyositis. , 1991, Journal of the American Academy of Dermatology.

[28]  E. Silverman,et al.  Treatment of dermatomyositis with intravenous gammaglobulin. , 1991, The American journal of medicine.

[29]  J. Mendell,et al.  The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis. , 1991, Archives of neurology.

[30]  P. Malleson.  Controversies in juvenile dermatomyositis. , 1990, The Journal of rheumatology. Supplement.

[31]  D. Isenberg,et al.  Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis. , 1990, Annals of the rheumatic diseases.

[32]  M. Slim,et al.  Treatment of duodenocutaneous fistula with somatostatin analog in a child with dermatomyositis. , 1990, Journal of pediatric gastroenterology and nutrition.

[33]  A. Engel,et al.  Microvascular changes in early and advanced dermatomyositis: A quantitative study , 1990, Annals of neurology.

[34]  C. Langman,et al.  Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. , 1990, The Journal of pediatrics.

[35]  S. Albani,et al.  Autoantibodies in juvenile dermatomyositis. , 1990, Clinical and experimental rheumatology.

[36]  L. P. Fong,et al.  Spontaneous regression of retinal neovascularisation in juvenile dermatomyositis. , 1990, Australian and New Zealand journal of ophthalmology.

[37]  S. Gabriel,et al.  NSAID induced ulcers. An emerging epidemic? , 1990, The Journal of rheumatology.

[38]  S. Rosalki.  Serum enzymes in disease of skeletal muscle. , 1989, Clinics in laboratory medicine.

[39]  A. G. Engel,et al.  Early ultrastructural alterations in adult dermatomyositis Capillary abnormalities precede other structural changes in muscle , 1989, Journal of the Neurological Sciences.

[40]  D. Vassilopoulos,et al.  Evidence for seasonal variation in polymyositis. , 1989, Neuroepidemiology.

[41]  M. Levin,et al.  Evidence for a novel picornavirus in human dermatomyositis , 1989, Annals of neurology.

[42]  S. Bowyer,et al.  Factor VIII related antigen and childhood rheumatic diseases. , 1989, The Journal of rheumatology.

[43]  F. Lapetina.  [Toxoplasmosis and dermatomyositis: a causal or casual relationship?]. , 1989, La Pediatria medica e chirurgica : Medical and surgical pediatrics.

[44]  H. Maricq,et al.  Childhood dermatomyositis: serial microvascular studies. , 1989, Pediatrics.

[45]  I. Nonaka,et al.  Perifascicular atrophic fibers in childhood dermatomyositis with particular reference to mitochondrial changes , 1988, Journal of the Neurological Sciences.

[46]  M. Hochberg.  Epidemiology of polymyositis/dermatomyositis. , 1988, The Mount Sinai journal of medicine, New York.

[47]  A. RodríguezNúñez,et al.  Polymyositis and dermatomyositis in childhood , 1988 .

[48]  K. Brandt,et al.  Relationships between clinical features and distribution of mononuclear cells in muscle of patients with polymyositis. , 1988, The Journal of rheumatology.

[49]  M. Borrelli,et al.  Ureteral necrosis in dermatomyositis. , 1988, The Journal of urology.

[50]  R. Touraine,et al.  Failure of warfarin in treatment of calcinosis universalis. , 1988, The American journal of medicine.

[51]  I. Targoff.  Laboratory manifestations of polymyositis/dermatomyositis. , 1988, Clinics in dermatology.

[52]  E. Gelfand,et al.  Reversal of chronic polymyositis following intravenous immune serum globulin therapy. , 1987, JAMA.

[53]  W. McCartney,et al.  Treatment of calcinosis universalis with low-dose warfarin. , 1987, The American journal of medicine.

[54]  J. Scott,et al.  Activation of complement and coagulation in juvenile dermatomyositis. , 1987, Arthritis and rheumatism.

[55]  H. Sarnat,et al.  Juvenile Dermatomyositis Induced by Toxoplasmosis , 1987, Journal of child neurology.

[56]  S. Katz,et al.  Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. , 1987, Reviews of infectious diseases.

[57]  R. Petty,et al.  Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis. , 1987, Arthritis and rheumatism.

[58]  L. Kagen,et al.  Creatine kinase activity inhibitor in sera from patients with muscle disease. , 1987, Arthritis and rheumatism.

[59]  L. Melton,et al.  Polymyositis-dermatomyositis and malignant lesions: does an association exist? , 1986, Mayo Clinic proceedings.

[60]  R. Clark,et al.  Juvenile dermatomyositis: histological findings and pathogenetic hypothesis for the associated skin changes. , 1986, The Journal of rheumatology.

[61]  A. Engel,et al.  Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. , 1986, Human pathology.

[62]  S. Ringel,et al.  Distribution of capillaries in normal and diseased human skeletal muscle , 1986, Muscle & nerve.

[63]  N. Bowles,et al.  DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHY , 1986, The Lancet.

[64]  Y. Harati,et al.  Childhood dermatomyositis in monozygotic twins , 1986, Neurology.

[65]  J. Mendell,et al.  Microvascular deposition of complement membrane attack complex in dermatomyositis. , 1986, The New England journal of medicine.

[66]  I. Targoff,et al.  The association between Mi-2 antibodies and dermatomyositis. , 1985, Arthritis and rheumatism.

[67]  R. Salamon,et al.  Prognosis in Juvenile Dermatopolymyositis: A Cooperative Retrospective Study of 70 Cases , 1985, Pediatric dermatology.

[68]  J. Callen,et al.  Recurrent Photosensitive Dermatitis Preceding Juvenile Dermatomyositis , 1985, Pediatric dermatology.

[69]  C. Fink,et al.  Immunogenetic studies of juvenile dermatomyositis. III. Study of antibody to organ-specific and nuclear antigens. , 1985, Arthritis and rheumatism.

[70]  B. Bernstein,et al.  Course of treated juvenile dermatomyositis. , 1984, The Journal of pediatrics.

[71]  J. Lott,et al.  The enzymology of skeletal muscle disorders. , 1984, Critical reviews in clinical laboratory sciences.

[72]  L. Pachman,et al.  Juvenile dermatomyositis and polymyositis. , 1984, Clinics in rheumatic diseases.

[73]  A. Gittelsohn,et al.  Mortality from polymyositis and dermatomyositis in the United States, 1968-1978. , 1983, Arthritis and rheumatism.

[74]  C. Blane,et al.  Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. , 1983, The Journal of pediatrics.

[75]  J. Bremer.  Carnitine--metabolism and functions. , 1983, Physiological reviews.

[76]  H. Maricq,et al.  Serial changes in nailfold capillary morphology in childhood dermatomyositis. , 1983, Arthritis and rheumatism.

[77]  M. Reyes,et al.  Myositis of chronic graft versus host disease , 1983, Neurology.

[78]  V. Dubowitz,et al.  Chronic graft versus host disease presenting with polymyositis. , 1983, British medical journal.

[79]  J. Friedman,et al.  Immunogenetic studies of juvenile dermatomyositis: HLA-DR antigen frequencies. , 1983, Arthritis and rheumatism.

[80]  J. Lian,et al.  Gamma-carboxyglutamate excretion and calcinosis in juvenile dermatomyositis. , 1982, Arthritis and rheumatism.

[81]  W. Crowe,et al.  Nailfold capillary abnormalities and clinical outcome in childhood dermatomyositis. , 1982, Arthritis and rheumatism.

[82]  A. Masi,et al.  Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis. , 1982, The Journal of rheumatology.

[83]  W. Crowe,et al.  Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. , 1982, Arthritis and rheumatism.

[84]  A. Chalmers,et al.  Juvenile dermatomyositis: medical, social and economic status in adulthood. , 1982, Canadian Medical Association journal.

[85]  E. Braunstein,et al.  Pneumatosis intestinalis in dermatomyositis. , 1980, The British journal of radiology.

[86]  J. Miller,et al.  Prolonged use of large intravenous steroid pulses in the rheumatic diseases of children. , 1980, Pediatrics.

[87]  L. Pachman,et al.  Juvenile dermatomyositis: a clinical and immunologic study. , 1980, The Journal of pediatrics.

[88]  R. Levy,et al.  γ‐Carboxyglutamate excretion and warfarin therapy , 1979 .

[89]  M. Shearn,et al.  Acute hepatitis B simulating dermatomyositis. , 1978, JAMA.

[90]  D. Tyrrell,et al.  Echovirus encephalitis and myositis in primary immunoglobulin deficiency. , 1978, Archives of disease in childhood.

[91]  P. Behan,et al.  Complement abnormalities in polymyositis , 1977, Journal of the Neurological Sciences.

[92]  R. L. Travers,et al.  COXSACKIE B NEUTRALISATION TITRES IN POLYMYOSITIS/DERMATOMYOSITIS , 1977, The Lancet.

[93]  Miller Rd,et al.  Persistance of activity in dermatomyositis of childhood. , 1977 .

[94]  J. Jacobs.  Methotrexate and azathioprine treatment of childhood dermatomyositis. , 1977, Pediatrics.

[95]  J. Brody,et al.  Childhood polymyositis: a case-control study. , 1976, American journal of epidemiology.

[96]  J. Lian,et al.  The presence of γ-carboxyglutamic acid in the proteins associated with ectopic calcification , 1976 .

[97]  S. Carpenter,et al.  The childhood type of dermatomyositis , 1976, Neurology.

[98]  B. Mawr,et al.  Dermatomyositis and malignancy. A review of the literature. , 1976, Annals of internal medicine.

[99]  K. Siegesmund,et al.  Chronic myopathy associated with coxsackievirus type A9. A combined electron microscopical and viral isolation study. , 1975, The New England journal of medicine.

[100]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .

[101]  B. Banker.  DERMATOMYOSITIS OF CHILDHOOD: ULTRASTRUCTURAL ALTERATIONS OF MUSCLE AND INTRAMUSCULAR BLOOD VESSELS , 1975, Journal of neuropathology and experimental neurology.

[102]  F. Mechler.  Changing electromyographic findings during the chronic course of polymyositis. , 1974, Journal of the neurological sciences.

[103]  E. Ouellette,et al.  The myositis of influenza. , 1973, Archives of neurology.

[104]  R. Matalon,et al.  Retinopathy in childhood dermatomyositis. , 1973, American journal of ophthalmology-glaucoma.

[105]  C. Fink,et al.  Lymphotoxin formation by lymphocytes and muscle in polymyositis. , 1972, The Journal of clinical investigation.

[106]  W. Engel,et al.  Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. , 1972, The New England journal of medicine.

[107]  R. D. Smith,et al.  Dermatomyositis with cerebral vasculitis in a patient with agammaglobulinemia. , 1972, A M A Journal of Diseases of Children.

[108]  W. N. Dawson,et al.  The epidemiology of polymyositis. , 1970, The American journal of medicine.

[109]  M. Victor,et al.  DERMATOMYOSITIS (SYSTEMIC ANGIOPATHY) OF CHILDHOOD , 1966, Medicine.

[110]  F. Rosen,et al.  DERMATOMYOSITIS AND FOCAL SCLERODERMA. , 1963, Pediatric clinics of North America.